KM Corporation (KOSDAQ:083550)
3,305.00
+25.00 (0.76%)
At close: Sep 4, 2026
KM Corporation Revenue
KM Corporation had revenue of 39.56B KRW in the quarter ending June 30, 2026, with 18.32% growth. This brings the company's revenue in the last twelve months to 144.10B, up 8.53% year-over-year. In the year 2025, KM Corporation had annual revenue of 135.41B with 3.26% growth.
Revenue (ttm)
144.10B
Revenue Growth
+8.53%
P/S Ratio
0.29
Revenue / Employee
567.31M
Employees
254
Market Cap
41.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 135.41B | 4.27B | 3.26% |
| Dec 31, 2024 | 131.14B | 3.36B | 2.63% |
| Dec 31, 2023 | 127.78B | -23.87B | -15.74% |
| Dec 31, 2022 | 151.65B | 8.40B | 5.87% |
| Dec 31, 2021 | 143.25B | -44.67B | -23.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JW Shinyak | 81.04B |
| Sewoon Medical | 66.53B |
| CG MedTech | 51.20B |
| OSTEONIC | 50.97B |
| DuChemBIO | 41.51B |
| Wonbiogen | 37.80B |
| SCL Science | 30.50B |
| Plasmapp | 12.02B |